GSK ac­cus­es Pfiz­er and BioN­Tech of mR­NA patent in­fringe­ment

GSK says it is owed a por­tion of Pfiz­er and BioN­Tech’s Covid-19 vac­cine sales in the lat­est patent suit filed against the Comir­naty part­ners.

In a law­suit filed in fed­er­al court in Delaware Thurs­day, the UK phar­ma claimed Pfiz­er and BioN­Tech ben­e­fit­ed from mR­NA re­search con­duct­ed more than a decade be­fore the pan­dem­ic. GSK said it se­cured the patents to those dis­cov­er­ies in 2015, when it ac­quired a por­tion of No­var­tis’ vac­cines busi­ness.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER